{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:44:34Z","timestamp":1773287074643,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T00:00:00Z","timestamp":1404777600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-493","type":"journal-article","created":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T09:01:48Z","timestamp":1404810108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Podocalyxin is a marker of poor prognosis in colorectal cancer"],"prefix":"10.1186","volume":"14","author":[{"given":"Tuomas","family":"Kaprio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Ferm\u00e9r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaana","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harri","family":"Mustonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"B\u00f6ckelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olle","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caj","family":"Haglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,8]]},"reference":[{"key":"4699_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 2012, 62: 10-29.","journal-title":"CA Cancer J Clin"},{"key":"4699_CR2","doi-asserted-by":"publisher","first-page":"779","DOI":"10.7326\/0003-4819-113-10-779","volume":"113","author":"JA Bufill","year":"1990","unstructured":"Bufill JA: Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990, 113: 779-788.","journal-title":"Ann Intern Med"},{"key":"4699_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ijc.10635","volume":"101","author":"B Iacopetta","year":"2002","unstructured":"Iacopetta B: Are there two sides to colorectal cancer?. Int J Cancer. 2002, 101: 403-408.","journal-title":"Int J Cancer"},{"key":"4699_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF02234301","volume":"44","author":"EC Gonzalez","year":"2001","unstructured":"Gonzalez EC, Roetzheim RG, Ferrante JM, Campbell R: Predictors of proximal vs. distal colorectal cancers. Dis Colon Rectum. 2001, 44: 251-258.","journal-title":"Dis Colon Rectum"},{"key":"4699_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1440-1746.2007.04923.x","volume":"23","author":"T Nawa","year":"2008","unstructured":"Nawa T, Kato J, Kawamoto H, Okada H, Yamamoto H, Kohno H, Endo H, Shiratori Y: Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol. 2008, 23: 418-423.","journal-title":"J Gastroenterol Hepatol"},{"key":"4699_CR6","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1200\/JCO.2010.34.3426","volume":"29","author":"ESE O\u2019Connor","year":"2011","unstructured":"O\u2019Connor ESE, Greenblatt DYD, LoConte NKN, Gangnon RER, Liou J-IJ, Heise CPC, Smith MAM: Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol. 2011, 29: 3381-3388.","journal-title":"J Clin Oncol"},{"key":"4699_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1083\/jcb.102.2.484","volume":"102","author":"RR Horvat","year":"1986","unstructured":"Horvat RR, Hovorka AA, Dekan GG, Poczewski HH, Kerjaschki DD: Endothelial cell membranes contain podocalyxin\u2013the major sialoprotein of visceral glomerular epithelial cells. J Cell Biol. 1986, 102: 484-491.","journal-title":"J Cell Biol"},{"key":"4699_CR8","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1158\/0008-5472.CAN-04-0240","volume":"64","author":"A Somasiri","year":"2004","unstructured":"Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, Gilks CB, Chia SK, Gelmon KA, Kershaw DB, Huntsman DG, McNagny KM, Roskelley CD: Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res. 2004, 64: 5068-5073.","journal-title":"Cancer Res"},{"key":"4699_CR9","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1182\/blood-2004-10-4077","volume":"105","author":"RR Doyonnas","year":"2005","unstructured":"Doyonnas RR, Nielsen JSJ, Chelliah SS, Drew EE, Hara TT, Miyajima AA, McNagny KMK: Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells. Blood. 2005, 105: 4170-4178.","journal-title":"Blood"},{"issue":"4","key":"4699_CR10","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1083\/jcb.98.4.1505","volume":"98","author":"D Kerjaschki","year":"1984","unstructured":"Kerjaschki D, Noronha-Blob L, Sacktor B, Farquhar MG: Microdomains of distinctive glycoprotein composition in the kidney proximal tubule brush border. J Cell Biol. 1984, 98 (4): 1505-1513.","journal-title":"J Cell Biol"},{"key":"4699_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1634\/stemcells.22-1-51","volume":"22","author":"MM Richards","year":"2003","unstructured":"Richards MM, Tan S-PS, Tan J-HJ, Chan W-KW, Bongso AA: The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells. 2003, 22: 51-64.","journal-title":"Stem Cells"},{"key":"4699_CR12","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1681\/ASN.2008070782","volume":"20","author":"JS Nielsen","year":"2009","unstructured":"Nielsen JS, McNagny KM: The role of podocalyxin in health and disease. J Am Soc Nephrol. 2009, 20: 1669-1676.","journal-title":"J Am Soc Nephrol"},{"key":"4699_CR13","doi-asserted-by":"publisher","first-page":"C616","DOI":"10.1152\/ajpcell.00149.2012","volume":"303","author":"MR Dallas","year":"2012","unstructured":"Dallas MR, Chen S-H, Streppel MM, Sharma S, Maitra A, Konstantopoulos K: Sialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells. Am J Physiol Cell Physiol. 2012, 303: C616-C624.","journal-title":"Am J Physiol Cell Physiol"},{"key":"4699_CR14","doi-asserted-by":"publisher","first-page":"C505","DOI":"10.1152\/ajpcell.00472.2008","volume":"296","author":"SN Thomas","year":"2009","unstructured":"Thomas SN, Schnaar RL, Konstantopoulos K: Podocalyxin-like protein is an E-\/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells. Am J Physiol Cell Physiol. 2009, 296: C505-C513.","journal-title":"Am J Physiol Cell Physiol"},{"key":"4699_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-bioeng-061008-124949","volume":"11","author":"K Konstantopoulos","year":"2009","unstructured":"Konstantopoulos K, Thomas SN: Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng. 2009, 11: 177-202.","journal-title":"Annu Rev Biomed Eng"},{"key":"4699_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2353\/ajpath.2010.090539","volume":"176","author":"Y-HY Hsu","year":"2010","unstructured":"Hsu Y-HY, Lin W-LW, Hou Y-TY, Pu Y-SY, Shun C-TC, Chen C-LC, Wu Y-YY, Chen J-YJ, Chen T-HT, Jou T-ST: Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7. Am J Pathol. 2010, 176: 12-","journal-title":"Am J Pathol"},{"key":"4699_CR17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/bjc.2011.295","volume":"105","author":"A Larsson","year":"2011","unstructured":"Larsson A, Johansson ME, Wangefjord S, Gaber A, Nodin B, Kucharzewska P, Welinder C, Belting M, Eberhard J, Johnsson A, Uhl\u00e9n M, Jirstr\u00f6m K: Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. Br J Cancer. 2011, 105: 666-672.","journal-title":"Br J Cancer"},{"key":"4699_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/1471-2407-12-282","volume":"12","author":"A Larsson","year":"2012","unstructured":"Larsson A, Fridberg M, Gaber A, Nodin B, Lev\u00e9en P, J\u00f6nsson G, Uhl\u00e9n M, Birgisson H, Jirstr\u00f6m K: Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer. BMC Cancer. 2012, 12: 282-","journal-title":"BMC Cancer"},{"key":"4699_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0006-291X(02)02844-9","volume":"300","author":"WM Schopperle","year":"2003","unstructured":"Schopperle WM, Kershaw DB, DeWolf WC: Human embryonal carcinoma tumor antigen, Gp200\/GCTM-2, is podocalyxin. Biochem Biophys Res Commun. 2003, 300: 285-290.","journal-title":"Biochem Biophys Res Commun"},{"key":"4699_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/hmg\/ddi487","volume":"15","author":"GG Casey","year":"2006","unstructured":"Casey GG, Neville PJP, Liu XX, Plummer SJS, Cicek MSM, Krumroy LML, Curran APA, McGreevy MRM, Catalona WJW, Klein EAE, Witte JSJ: Podocalyxin variants and risk of prostate cancer and tumor aggressiveness. Hum Mol Genet. 2006, 15: 735-741.","journal-title":"Hum Mol Genet"},{"key":"4699_CR21","doi-asserted-by":"publisher","first-page":"e18715","DOI":"10.1371\/journal.pone.0018715","volume":"6","author":"X Meng","year":"2011","unstructured":"Meng X, Ezzati P, Wilkins JA: Requirement of podocalyxin in TGF-beta induced epithelial mesenchymal transition. PLoS One. 2011, 6: e18715-","journal-title":"PLoS One"},{"key":"4699_CR22","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1371\/journal.pone.0000237","volume":"2","author":"JS Nielsen","year":"2007","unstructured":"Nielsen JS, Graves ML, Chelliah S, Vogl AW, Roskelley CD, McNagny KM: The CD34-related molecule podocalyxin is a potent inducer of microvillus formation. PLoS One. 2007, 2: e237-","journal-title":"PLoS One"},{"key":"4699_CR23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallionimeni A, B\u00e4rlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallionimeni O-P: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998, 4: 844-847.","journal-title":"Nat Med"},{"key":"4699_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/256495a0","volume":"256","author":"G K\u00f6hler","year":"1975","unstructured":"K\u00f6hler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975, 256: 495-497.","journal-title":"Nature"},{"key":"4699_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10585-011-9446-0","volume":"29","author":"JA Cipollone","year":"2012","unstructured":"Cipollone JA, Graves ML, K\u00f6bel M, Kalloger SE, Poon T, Gilks CB, McNagny KM, Roskelley CD: The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma. Clin Exp Metastasis. 2012, 29: 239-252.","journal-title":"Clin Exp Metastasis"},{"key":"4699_CR26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/jclinpath-2011-200402","volume":"65","author":"J Hagstr\u00f6m","year":"2012","unstructured":"Hagstr\u00f6m J, Heikkil\u00e4 A, Siironen P, Louhimo J, Heiskanen I, M\u00e4enp\u00e4\u00e4 H, Arola J, Haglund C: TLR-4 expression and decrease in chronic inflammation: indicators of aggressive follicular thyroid carcinoma. J Clin Pathol. 2012, 65: 333-338.","journal-title":"J Clin Pathol"},{"key":"4699_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/jclinpath-2011-200359","volume":"65","author":"H Yasuoka","year":"2012","unstructured":"Yasuoka H, Tsujimoto M, Inagaki M, Kodama R, Tsuji H, Iwahashi Y, Mabuchi Y, Ino K, Sanke T, Nakamura Y: Clinicopathological significance of podocalyxin and phosphorylated ezrin in uterine endometrioid adenocarcinoma. J Clin Pathol. 2012, 65: 399-402.","journal-title":"J Clin Pathol"},{"key":"4699_CR28","first-page":"1698","volume":"51","author":"K Takeuchi","year":"2004","unstructured":"Takeuchi K, Kuwano H, Tsuzuki Y, Ando T, Sekihara M, Hara T, Asao T: Clinicopathological characteristics of poorly differentiated adenocarcinoma of the colon and rectum. Hepatogastroenterology. 2004, 51: 1698-1702.","journal-title":"Hepatogastroenterology"},{"key":"4699_CR29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/gutjnl-2011-300865","volume":"61","author":"M Yamauchi","year":"2012","unstructured":"Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, Liao X, Waldron L, Hoshida Y, Huttenhower C, Chan AT, Giovannucci E, Fuchs C, Ogino S: Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut. 2012, 61: 847-854.","journal-title":"Gut"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-493\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T21:53:26Z","timestamp":1468360406000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,8]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4699"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-493","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,8]]},"article-number":"493"}}